FOXBusiness.com: Valeant in talks to buy Actavis for over $13 billion: WSJ

FOXBusiness.com FOX Business Network - The Power to Prosper

Valeant in talks to buy Actavis for over $13 billion: WSJ Apr 26th 2013, 23:47 Canada's biggest listed drug maker, Valeant Pharmaceuticals International Inc , is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, Wall Street Journal reported, citing people familiar with the matter.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions